Prospective CT Assessment After DCB
PREVAIL
PRospective Evaluation of Vascular Alterations in CT Angiography After Intervention With Drug-coated Balloon (PREVAIL) Study
2 other identifiers
observational
165
1 country
1
Brief Summary
This prospective, multicenter observational cohort study aims to investigate changes in target lesion hemodynamic parameters, diameter stenosis, plaque characteristics of CCTA before and after the DCB procedure and evaluate their association with clinical outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2025
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2025
CompletedFirst Submitted
Initial submission to the registry
August 8, 2025
CompletedFirst Posted
Study publicly available on registry
January 28, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2031
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2032
January 28, 2026
January 1, 2026
6 years
August 8, 2025
January 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in ΔFFR CT before and after DCB procedure
From baseline CCTA to follow-up CCTA performed 2 years after the index PCI
Secondary Outcomes (2)
Changes in plaque characteristics before and after DCB procedure
From baseline CCTA to follow-up CCTA performed 2 years after the index PCI
Changes in diameter stenosis before and after DCB procedure
From baseline CCTA to follow-up CCTA performed 2 years after the index PCI
Study Arms (1)
Patients treated with a drug-coated balloon for de novo lesions.
Patients who underwent DCB within 3 months after CCTA and whose clinical presentation remained largely unchanged from the time of CCTA.
Eligibility Criteria
Patients who took coronary computed tomography angiography (CCTA) and received drug-coated balloon (DCB) treatment for coronary artery disease
You may qualify if:
- Patients with Age ≥ 19
- Patients who took CCTA and were found to have coronary artery disease requiring reperfusion
- Patients who underwent DCB within 3 months after CCTA and whose clinical presentation remained largely unchanged from the time of CCTA.
- The target lesion is a de novo lesion with a vessel diameter between 2.25mm and 3.00mm
- Patients deemed suitable for coronary intervention using drug-coated balloon by clinical assessment
- Patients who have been adequately informed about this study and have voluntarily provided written consent to participate.
You may not qualify if:
- The target lesion is an in-stent restenosis lesion
- Patient requiring emergency salvage stenting in target lesion
- Patients with a stent previously implanted in the same vessel
- Lesions involving chronic total occlusion or prior coronary artery bypass grafting (CABG).
- Patients with eGFR (estimated glomerular filtration rate) \< 45 ml/min/1.73mm2
- Patients with coronary artery calcium score ≥ 1000 as determined by CCTA
- Patients with an expected survival of less than 5 years
- Pregnant or breastfeeding patients
- Patients deemed inappropriate to participate in this study based on the judgment of study investigators
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Seoul National University Hospitallead
- Ulsan University Hospitalcollaborator
- National Health Insurance Service Ilsan Hospitalcollaborator
- KangWon National University Hospitalcollaborator
- Korea University Guro Hospitalcollaborator
- Sejong General Hospitalcollaborator
- Hanyang University Seoul Hospitalcollaborator
Study Sites (1)
Seoul National University Hospital
Seoul, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 8, 2025
First Posted
January 28, 2026
Study Start
August 1, 2025
Primary Completion (Estimated)
August 1, 2031
Study Completion (Estimated)
December 1, 2032
Last Updated
January 28, 2026
Record last verified: 2026-01